OBJECTIVES: The American Academy of Pediatrics published bronchiolitis clinical practice guidelines in 2014 recommending against the routine use of bronchodilators, chest radiographs, or respiratory viral testing in children with a clinical diagnosis of bronchiolitis. Our aim in this project was to align care with the American Academy of Pediatrics clinical practice guidelines by decreasing the overuse of these interventions. METHODS: This study included patients who were admitted to a non-ICU setting with a primary or secondary diagnosis of bronchiolitis. The team used a multidisciplinary kickoff event to understand the problem and develop interventions, including sharing provider-specific data and asking providers to sign a pledge to reduce use. We used a novel, real-time data dashboard to collect and analyze data. RESULTS: Special cause variation on control charts indicated improvement for all outcomes for inpatients during the intervention season. Pre- and postanalyses in which we compared baseline to intervention values for all admitted patients and patients who were discharged from the emergency department or urgent care revealed a significant reduction in the ordering of chest radiographs (from 22.7% to 13.6%; P ≤ .001), respiratory viral testing (from 12.5% to 9.8%; P = .001), and bronchodilators (from 17.5% to 10.3%; P = .001) without changes in balancing measures (eg, hospital readmission within 7 days [1.7% (preanalysis) and 1.0% (postanalysis); P = .21]) for bronchiolitis. CONCLUSIONS: This multidisciplinary improvement initiative resulted in a significant reduction in use for bronchiolitis care at our institution. Our approach, which included a novel, real-time data dashboard and interventions such as individual providers pledging to reduce use, may have the potential to reduce overuse in other settings and diseases.
OBJECTIVES: The American Academy of Pediatrics published bronchiolitis clinical practice guidelines in 2014 recommending against the routine use of bronchodilators, chest radiographs, or respiratory viral testing in children with a clinical diagnosis of bronchiolitis. Our aim in this project was to align care with the American Academy of Pediatrics clinical practice guidelines by decreasing the overuse of these interventions. METHODS: This study included patients who were admitted to a non-ICU setting with a primary or secondary diagnosis of bronchiolitis. The team used a multidisciplinary kickoff event to understand the problem and develop interventions, including sharing provider-specific data and asking providers to sign a pledge to reduce use. We used a novel, real-time data dashboard to collect and analyze data. RESULTS: Special cause variation on control charts indicated improvement for all outcomes for inpatients during the intervention season. Pre- and postanalyses in which we compared baseline to intervention values for all admitted patients and patients who were discharged from the emergency department or urgent care revealed a significant reduction in the ordering of chest radiographs (from 22.7% to 13.6%; P ≤ .001), respiratory viral testing (from 12.5% to 9.8%; P = .001), and bronchodilators (from 17.5% to 10.3%; P = .001) without changes in balancing measures (eg, hospital readmission within 7 days [1.7% (preanalysis) and 1.0% (postanalysis); P = .21]) for bronchiolitis. CONCLUSIONS: This multidisciplinary improvement initiative resulted in a significant reduction in use for bronchiolitis care at our institution. Our approach, which included a novel, real-time data dashboard and interventions such as individual providers pledging to reduce use, may have the potential to reduce overuse in other settings and diseases.
Authors: Nusrat Homaira; Louise K Wiles; Claire Gardner; Charlotte J Molloy; Gaston Arnolda; Hsuen P Ting; Peter Damian Hibbert; Jeffrey Braithwaite; Adam Jaffe Journal: BMJ Qual Saf Date: 2019-04-02 Impact factor: 7.035
Authors: Dorine Borensztajn; Joany M Zachariasse; Susanne Greber-Platzer; Claudio F Alves; Paulo Freitas; Frank J Smit; Johan van der Lei; Ewout W Steyerberg; Ian Maconochie; Henriëtte A Moll Journal: PLoS One Date: 2021-05-05 Impact factor: 3.240
Authors: Mehrvash Haghighi; Dayanandan Adhimoolam; Ricky Kwan; Melissa Gitman; Maria McGuire; Damodara R Mendu; Adolfo Firpo-Betancourt; Russell B McBride; Carlos Cordon-Cardo; Catherine K Craven Journal: J Pathol Inform Date: 2022-01-05
Authors: Libby Haskell; Emma J Tavender; Sharon O'Brien; Catherine L Wilson; Franz E Babl; Meredith L Borland; Rachel Schembri; Francesca Orsini; Elizabeth Cotterell; Nicolette Sheridan; Ed Oakley; Stuart R Dalziel Journal: BMC Health Serv Res Date: 2021-11-29 Impact factor: 2.655